ChemoCentryx Inc
NASDAQ:CCXI
Gross Margin
ChemoCentryx Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | US |
Market Cap | 3.7B USD |
Gross Margin |
49%
|
Country | US |
Market Cap | 287.7B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 168.6B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 113.7B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 109.5B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 134.1B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 83.8B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 54.4B USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 33B USD |
Gross Margin |
75%
|
Country | KR |
Market Cap | 38.6T KRW |
Gross Margin |
48%
|
Profitability Report
View the profitability report to see the full profitability analysis for ChemoCentryx Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on ChemoCentryx Inc's most recent financial statements, the company has Gross Margin of 48.9%.